A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.
Clinical trial NCT00199836 · COMPLETED
Trial details
- NCT number
- NCT00199836
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-03
- Primary completion
- 2005-09-05
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.